After finishing all process Initial Public Offering (IPO) Lottery of Orion Pharma will be held on Thursday, 07 February 2013 at Engineering Institute at 11AM in the city. Company source confirm this to Share News 24 today.
There are 252 crore, 88 Lac and 44 thousands taka deposited against demanded 240 crore by the company. Which is 1.05 times more against company’s demand. Therefore, general investors deposited 184 crore, 33 Lac and 26 thousand taka, Affected investors deposited 27 crore, 77 Lac and 10 Thousand taka, Non-resident investors deposited 8 crore, 34 Lac and 34 Thousand taka and Mutual Fund deposited 32 crore, 5 Lac and 74 Thousand taka for IPO share of this Company.
From 6-10th January Orion Pharma collected IPO application from resident investors. NRB investors get 9 days more time to apply.
Orion Pharma will release total of 4 crore ordinary share to the capital Market. Face Value of this share is 10 taka and premium 50 taka.
As per Audited financial report on 31st December 2011, earning per share (EPS) of this company 5.57 taka, Net Asset value per share (NAV) 76.87 taka.
ICB Asset management company working for Orion Pharma.
Orion_Pharma_Bank and Branch Code
Orion Pharma General Public
Non – Resident Bangladeshi (NRB)
Affected Small Investor
Orion Pharma Mutual Fund
Orion Pharma Distribution of Refund Warrant
There are 252 crore, 88 Lac and 44 thousands taka deposited against demanded 240 crore by the company. Which is 1.05 times more against company’s demand. Therefore, general investors deposited 184 crore, 33 Lac and 26 thousand taka, Affected investors deposited 27 crore, 77 Lac and 10 Thousand taka, Non-resident investors deposited 8 crore, 34 Lac and 34 Thousand taka and Mutual Fund deposited 32 crore, 5 Lac and 74 Thousand taka for IPO share of this Company.
From 6-10th January Orion Pharma collected IPO application from resident investors. NRB investors get 9 days more time to apply.
Orion Pharma will release total of 4 crore ordinary share to the capital Market. Face Value of this share is 10 taka and premium 50 taka.
As per Audited financial report on 31st December 2011, earning per share (EPS) of this company 5.57 taka, Net Asset value per share (NAV) 76.87 taka.
ICB Asset management company working for Orion Pharma.
Orion_Pharma_Bank and Branch Code
Orion Pharma General Public
Non – Resident Bangladeshi (NRB)
Affected Small Investor
Orion Pharma Mutual Fund
Orion Pharma Distribution of Refund Warrant
